Epidemiological studies are the basis for
|
|
- Evangeline Lyons
- 6 years ago
- Views:
Transcription
1 XASIM Feb p /5/01 9:27 AM Page 45 THE EPIDEMIOLOGY OF MIGRAINE AND HEADACHE DISORDERS* Hartmut Göbel, MD, PhD Kiel Pain Clinic, Germany ABSTRACT The development of the diagnostic and classification criteria for headache disorders from the International Headache Society has benefited not only practicing headache specialists but also epidemiologists. We now have a wealth of data from international epidemiological studies on the prevalence and cost of migraine and other headache disorders. The data reveal the significant impact these disorders have on society in terms of direct and indirect costs. Given the extremely high prevalence of migraine and tension-type headache, research efforts should focus on these 2 headache disorders; greater emphasis should be placed on diagnosis during medical training, and neurological pain treatment centers should be established. This paper reviews the results of many international studies to offer a global perspective on migraine and headache disorders. (Advanced Studies in Medicine 2001;1(2):44 49) *This article is based on a presentation given by Dr. Göbel at the Fifth Congress of the European Federation of Neurological Societies 2000, Copenhagen, Denmark. Epidemiological studies are the basis for understanding diverse syndromes such as headache disorders and for developing new and effective treatments. The prerequisite for the reliability and validity of epidemiological studies is an exact classification of headache syndromes. The first classification that has been accepted worldwide was initiated by the International Headache Society (IHS) and published in The World Health Organization has published a separate manual as a headache classification supplement to the Tenth Revision of the International Classification of Diseases (ICD-10). 2,3 The IHS classification criteria are of inestimable value for research into headache syndromes and represent a crucial milestone in the scientific history of headache research. Interestingly, there is no other group of neurological disorders that can be diagnosed with the same degree of precision. Without these criteria for classification, the advances in headache therapy in recent years would not have been possible. Epidemiological studies are based on different population sources. These sources may be defined sections of the population, such as a certain city or rural area. The patients may come from general practice or from a specialized headache clinic. Ideally, however, a sample that is representative of the population as a whole will be selected so conclusions that are valid for the entire population can be drawn. Correspondence to: Dr. Hartmut Göbel, Heikendorfer Weg 9-27, D Kiel, Germany. h.gobel@neurologie.uni-kiel.de. HEADACHE PREVALENCE WORLDWIDE Some of the early headache epidemiology studies in Advanced Studies in Medicine 45
2 XASIM Feb p /5/01 9:27 AM Page 46 Denmark in which the IHS classification method was used have emerged as the gold standard for other studies worldwide. 4,5 Several international studies have ascertained the lifetime prevalence of headache, and the results show that in men, the prevalence ranges from 60% to 93%. In women, the lifetime prevalence is higher, ranging from 82% to 99% (Table 1). 4,6-9 These data clearly show that headache is a fact of life, with the vast majority of people experiencing headaches at least once in their lifetime. The 1-year prevalence rates are more varied among several countries, ranging from 40% to 91% for women and 19% to 84% for men. However, the data reveal that the vast majority of people suffer from headache at some time within a 1-year period. 7,10-15 HEADACHE AND MIGRAINE PREVALENCE IN CHILDREN Numerous studies have investigated the prevalence of headache and migraine in children. In one study, headache occurred in 4% of 3-year-olds. By the age of 5, as many as 20% of children had headaches, and 47% of children between the ages of 6 and 7 reported that they had suffered from headaches. In the 6- to 7- year-old group, the prevalence of migraine was 3.2%. Headaches occurred in 57% of children between the ages of 7 and 15, by which time migraine prevalence almost reached the adult rate of around 10%. 16 It is interesting to note that the studies have shown a marked increase in migraine prevalence during the last several decades. In 1974, migraine attacks occurred in 2% of boys and 2% of girls aged 6 or younger. In 1992, migraine prevalence in this age group rose to 6.3% in boys and 5% in girls a 3- fold increase. 16 We investigated the 1- year prevalence of headache among children in various school classes in Germany and found an interesting correlation between headache prevalence and the type of school. Headaches were observed to be most frequent in remedial and elementary schools, the lowest school levels in Germany (42% and 45%, respectively) but the prevalence declined to 24% by grammar school, the highest school level in Germany. 17 MIGRAINE PREVALENCE WORLDWIDE The lifetime prevalence of migraine has been shown to be consistent across countries (Table 1), ranging from 6% to 12% in men and 15% to 25% in women. 4,5,7,9,11,18-20 Studies of 1-year prevalence by age have shown that the maximum prevalence occurs between the ages of 30 and 50 in both men and women, and that the 1-year prevalence in this age range is distinctly higher in women than in men. It is often assumed that migraine prevalence decreases after the age of 50 or 60. Instead, the data show that it can persist to the age of 70 or So, although migraine is not fatal, it is a chronic, debilitating disease. Table 1.Worldwide Lifetime Prevalence of Headache Disorders (%) Headache Migraine Tension-type Cluster (ref) (ref) headache (ref) headache (ref) Country Men Women Men Women Men Women Men & Women Canada 10 (19) 23 (19) 22 (19) 36 (19) China 0.7 (25) Denmark 93 (4) 99 (4) 8 (4) 25 (4) 69 (4) 88 (4) 12 (5) 24 (5) Finland 69 (7)* 83 (7)* 9 (7) 28 (7) 35 (7) 42 (7) France 6 (18) 18 (18) Germany 60 (17) 82 (17) 7 (9) 15 (9) 36 (9) 39 (9) 0.4 (26) Italy 0.08 (29) Republic of San Marino 9 (11) 18 (11) 0.07 (27) Sweden 0.09 (28) UK 69 (8) 94 (8) 29 (8) 35 (8) (30) USA 91 (6) 95 (6) 7 (20) 16 (20) 14 (23)* 26 (23)* 2.4 (31) 41 (24) 50 (24) = not available. *1-year prevalence 46 Vol. 1, No. 2 February 2001
3 XASIM Feb p /5/01 9:27 AM Page 47 Migraine patients often suffer not only from their primary pain syndrome but also from associated disorders that frequently make treatment especially complicated and expensive. A recent study showed that migraine is very strongly associated with other disabling and potentially life-threatening disorders, including epilepsy, depression, anxiety states, myocardial infarction, and stroke. 22 EPIDEMIOLOGY OF OTHER HEADACHE DISORDERS As with migraine and general headache, there is a consistent lifetime prevalence of tension-type headache (TTH) across several countries. In men the lifetime prevalence of TTH ranges from 14% to 69% and in women from 26% to 88% (Table 1). Thus, TTH is considerably more common than migraine but unlike migraine, no significant gender-related differences have been observed. 4,7-9,19,23,24 The data for cluster headache are not as current as they are for other primary headache disorders. However, various studies have indicated that the lifetime prevalence of cluster headache is between 0.005% and 2.4% (Table 1) It may therefore be assumed that 1 person in a 1000 suffers from cluster headache. Regarding secondary headaches, the most frequent type is hangover headache, with a lifetime prevalence of 72%. This is followed by fever-related headache (63%), especially in cases of colds, followed by headache accompanying metabolic disorders (22%), and headache associated with diseases of the nose and sinuses (15%). Substance-induced, vascular, and nonvascular intracranial headaches, as well as headaches associated with disorders of the eye, neck, and ear have a lifetime prevalence of 1% to 3%. Thus, compared with the primary headache types, secondary headache has considerably less impact. 32 Our epidemiological study in Germany has shown that TTH is the most frequent headache, comprising 54% of all headache syndromes, and that migraine is responsible for 38% of all headache complaints. In other words, 92% of all headaches are attributable to only 2 types of headache disorders. Conversely, more than 163 types of headaches in the IHS classification account for only 8% of all headaches. 33 Thus, the main research effort for the future should be devoted to TTH and migraine. PATTERNS OF HEALTHCARE UTILIZATION In a nationwide survey of migraine in Germany, we found that migraine is underdiagnosed. Nearly two thirds of patients who satisfied the IHS diagnostic criteria for migraine were not identified as migraine patients. BY MIGRAINEURS Representative studies have shown that 16% of all migraineurs had consulted specialists in the previous year, and that 56% had frequently consulted general practitioners (GPs)/primary care physicians (PCPs). 34 Forty-nine percent of migraineurs had taken medication in the previous year to treat their migraine. 34 More than three times as many over-the-counter drugs as prescription medicines were taken. 35 Emergency treatments were necessary for 19% of migraine patients, and 8% of migraine patients had undergone inpatient treatment for their headaches. 36,37 In the preceding year, supplementary diagnostic techniques, such as computed tomography or magnetic resonance imaging, had been used for 3% of migraine patients, and 2% of migraine patients required inpatient treatment for their headaches. 35 Because approximately 1 in 10 persons suffers from migraine, the healthcare utilization by migraineurs can be expensive. In a nationwide survey of migraine in Germany, we found that migraine is underdiagnosed. Nearly two thirds of patients who satisfied the IHS diagnostic criteria for migraine were not identified as migraine patients. Migraine was most often diagnosed by neurologists (35%), followed by internists (32%), GPs/PCPs (27%), anesthesiologists (18%), and orthopedists (16%). 7 These findings suggest that training in headache diagnosis and therapy is deficient. Additional surveys have shown that migraine is also undertreated. Data from western European countries on triptan use in migraine show that even in the countries with the highest consumption of triptans (Norway, Denmark, and Sweden), the dosage/capita/year is less than 0.5. By contrast, supplies for patients in Germany, Spain, Belgium, Austria, Italy, Greece, Ireland, and Portugal are below 0.1 dosage units/capita/year, despite comparable prevalence data. The European average is 0.12 dosage units/capita/year. So, we assume that many migraine patients who could Advanced Studies in Medicine 47
4 XASIM Feb p /5/01 9:27 AM Page 48 benefit from treatment are not identified as migraine patients and are not receiving the level of pharmacotherapy that could benefit them. This leads to unnecessary individual suffering and substantial costs for affected individuals and society as a whole. A Canadian study has shown that only one third of headache patients return after the first consultation, whereas 65% never return. Of these, 45% were satisfied with the treatment first recommended and did not require any further consultation. However, 17% said they did not come back because they could not tolerate the medicine. Thirty-eight percent indicated that they did not feel they were being taken seriously. 19 Together, these data clearly indicate that migraine patients are not receiving adequate care under the existing healthcare systems in various countries around the world. COSTS OF HEADACHES Direct costs of migraine and headache disorders include those associated with diagnosis and direct medical treatment. Indirect costs arise from the inability to work and from premature death. Intangible costs stem from disease-related suffering and reduction in quality of life. For migraine, in particular, the direct costs have been thoroughly investigated. Of each country s respective total health service budget, England spent 0.1%, France spent 1%, and the Netherlands spent 0.3% on migraine In France, that figure translates into an average of 150 Euro ($133) spent per migraine patient. Interestingly, only 10% of migraine patients are responsible for 70% of the total cost of migraine in France. 39 The direct costs of migraine treatment are much higher in the United States, where $817 per migraineur per year is spent on direct treatment. 41 Inpatient treatments incur significant cost. Health insurance data from Germany show that of all chronic diseases, chronic pain disorders are the third most frequent reason for emergency treatment. Since 1995, the number of cases of inpatient treatment for chronic pain disorders has increased by 11% a year, reinforcing the urgent need to establish inpatient treatment facilities that can concentrate on the treatment of such neurological pain syndromes. 34 Using the same data source, the average cost per patient for chronic pain disorders was determined (Table 2). The most expensive disorder is chronic TTH, which accounts for about Euro ($13,300), followed by basilar migraine and central pain syndromes. Specialized treatment strategies must therefore be devised to avoid unnecessary costs. Primary headache syndromes are a major factor in the cost of chronic pain disorders, yet standard care in acute hospitals includes no specialized treatment strategies. In Germany every year, approximately 350,000 patients receive acute inpatient treatment for headaches at a cost of 670 million Euro ($590 million). Extrapolating these figures for Europe, this figure swells to 3.1 billion Euro ($2.75 billion) per year. As a rule, these patients are given unspecialized treatment without specific therapeutic strategies, and they are treated outside neurological facilities. The cost data underscore the urgent need to establish specialized academic headache centers and neurological centers as a standard of care, just as has been done for stroke. 34 Indirect costs of migraine and headache-related disorders pose an enormous economic burden. For every 1000 employees with migraine, roughly 270 working days per year are lost through inability to work. For TTH, 920 working days per year are lost in every 1000 employees. 4 The cost of work time lost per migraine patient is about 4000 Euro ($3540) a year, and the cost of reduced productivity is even higher (around 5000 Euro or $4430). It must be assumed, Table 2. Inpatient Treatment of Chronic Pain Disorders in Nonspecialized Hospitals in Germany Average costs per patient DM US $ TTH Basilar migraine Thalamus pain Atypical facial pain Trigeminal neuralgia Drug-induced headache Migraine without aura Data from Göbel H, Buschmann P, Heinze A, Heinze-Kuhn K. [Epidemiology and socioeconomic consequences of migraine and headache diseases]. Versicherungsmedizin. 2000;52(1): Vol. 1, No. 2 February 2001
5 XASIM Feb p /5/01 9:27 AM Page 49 therefore, that in the European Union, headache disorders account for the loss of some 20 billion Euro ($35 billion) every year, making headaches the third most expensive neurological disease after dementia and stroke. The indirect costs of other neurological diseases, including multiple sclerosis and Parkinson s disease, are far less than the costs associated with TTH, migraine, and related headache disorders. 42 CONCLUSION The results of epidemiological studies show that the prevalence of migraine and other headache disorders is consistently high in countries throughout the world, and that the impact of these disorders on society is significant in terms of direct and indirect costs. Because headache disorders present a major international health problem, research into the pathogenesis of headache disorders should be given clear priority. In addition, specialized neurological headache facilities need to be created and education in the diagnosis and management of headache disorders must be improved. REFERENCES 1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia.1988;8(suppl 7): World Health Organization. ICD-10 Guide for Headaches. Cephalalgia.1997;17(suppl 19): Göbel H. ICD-10 - Richtlinien f r die Klassifikation und Diagnostik von Kopfschmerzen. Berlin: Springer Verlag; 1999: Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol.1991;44(11): Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int J Epidemiol. 1995;24(3): Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261(15): Nikiforow R. Headache in a random sample of 200 persons: a clinical study of a population in northern Finland. Cephalalgia. 1981;1(2): Crisp AH, Kalucy RS, McGuinness B, Ralph PC, Harris G. Some clinical, social and psychological characteristics of migraine subjects in the general population. Postgrad Med J.1977;53(625): Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia. 1994;14(2): O Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol. 1994;23(5): D Alessandro R, Benassi G, Lenzi PL, et al. Epidemiology of headache in the Republic of San Marino. J Neurol Neurosurg Psychiatry. 1988;51(1): Post D, Gubbels JW. Headache: an epidemiological survey in a Dutch rural general practice. Headache. 1986; 26(3): Newland CA, Illis LS, Robinson PK, Batchelor BG, Waters WE. A survey of headache in an English city. Res Clin Stud Headache. 1978;5: Mitsikostas DD, Tsaklakidou D, Athanasiadis N, Thomas A. The prevalence of headache in Greece: correlations to latitude and climatological factors. Headache. 1996;36(3): Michel P, Pariente P, Duru G, Dreyfuss J-P, Chabriat H, Henry P. MIG ACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia. 1996;16(1): Matti L, Sillanpää M. Headache in children. In: Olesen J, ed. Headache Classification and Epidemiology.New York: Raven; 1994: Göbel H. Die Kopfschmerzen. Berlin: Springer Verlag; 1997: Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Groupe de Recherche Interdisciplinaire sur la Migraine. Cephalalgia.1992;12(4): Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RFA. Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci. 1992; 19(3): Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res. 1991;37(1): Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1): Merikangas KR, Fenton B. Comorbidity of migraine and somatic disorders. In: Olesen J, ed. Headache Classification and Epidemiology. New York: Raven; 1994: Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA.1998;279(5): Ziegler DK, Hassanein RS, Couch JR. Characteristics of life headache histories in a nonclinic population. Neurology. 1977;27(3): Zhao F, Tsay J-Y, Cheng X. Epidemiology of migraine: a survey in 21 provinces of the Peoples Republic of China, Headache. 1988;28(8): Heyck H. Clusterkopfschmerz [( Cluster -headache (Bing- Horton syndrome?)]. Fortschr Neurol Psychiatr Grenzgeb. 1976;44(2): Advanced Studies in Medicine 49
6 XASIM Feb p /5/01 9:27 AM Page D Alessandro R, Gamberini G, Benassi G, Morganti G, Cortelli P, Lugaresi E. Cluster headache in the Republic of San Marino. Cephalalgia. 1986;6(3): Ekbom K, Ahlborg B, Schele R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache. 1978;18(1): Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia. 1998;18(3): Hardman RA, Hopkins EJ. A survey of migrainous neuralgia. J Coll Gen Pract. 1966;11: Kudrow L. Cluster Headache: Mechanisms and Management. New York: Oxford University Press; Rasmussen BK, Olesen J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992;42(6): Göbel H, Buschmann P, Heinze A, Heinze-Kuhn K. [Epidemiology and socioeconomic consequences of migraine and headache diseases]. Versicherungsmedizin. 2000;52(1): Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilization of medical services: a Danish population study. J Epidemiol Community Health. 1992;46(4): Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci. 1993;20(2): Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample. Headache.1992;32(5): Stang P, Osterhaus J. Impact of migraine in the United States: data from the National Health Interview Survey. Headache. 1993;33(1): Blau JN, Drummond MF. Migraine. London: Office of Health Economics; 1991: Chicoye A, Auray JP, Duru G. The burden of migraine in France. In: Chytil MK, ed. Proceedings of the Fifth International Conference on System Science in Health Care. Prague: Omnipress; 1992: Van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FFH. Societal perspective on the burden of migraine in the Netherlands. Pharmacoeconomics. 1995;7(2): Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and labor costs of migraine in the US. Pharmacoeconomics. 1992;2(1): Jes Olesen. Preface. In: Jes Olesen, ed. Headache Classification and Epidemiology. New York, NY: Raven Press; 1994:xxii. 50 Vol. 1, No. 2 February 2001
The Economic and Social Impact of Migraine Key Words
Paper Eur Neurol 1994;34(suppl 2):12-17 W.F. Walter F. Stewart a R.B. Richard B. Lipton b a Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Md., b Departments of Neurology,
Socio-economic costs of migraine
J Headache Pain (2001) 2:S15 S19 Springer-Verlag 2001 MIGRAINE AND DISABILITY Rosanna Cerbo Marina Pesare Cinzia Aurilia Valeria Rondelli Piero Barbanti Socio-economic costs of migraine R. Cerbo ( ) M.
Epidemiology of migraine
J Headache Pain (2003) 4:S18 S22 Springer-Verlag 2003 GLOBAL BURDEN Gian Camillo Manzoni Paola Torelli Epidemiology of migraine G.C. Manzoni ( ) P. Torelli Headache Centre, Institute of Neurology, University
Prevalence of headache in an elderly population: attack frequency, disability, and use of medication
J Neurol Neurosurg Psychiatry 2001;70:377 381 377 Department of Neurological Sciences, La Sapienza University, Via dell Amba Aradam 21, 00184 Rome Rome, Italy M Prencipe A R Casini C Ferretti M Santini
Migraine Diagnosis and Treatment: Results From the American Migraine Study II
Migraine Diagnosis and Treatment: Results From the American Migraine Study II Richard B. Lipton, MD; Seymour Diamond, MD; Michael Reed, PhD; Merle L. Diamond, MD; Walter F. Stewart, MPH, PhD Objective.
Prevalence of primary headaches in Germany: results of the German Headache Consortium Study
J Headache Pain (2012) 13:215 223 DOI 10.1007/s10194-012-0425-x ORIGINAL Prevalence of primary headaches in Germany: results of the German Headache Consortium Study M-S Yoon Z. Katsarava M. Obermann G.
Epidemiology and Burden of Headache
D A N I S H H E A D A C H E C E N T E R Epidemiology and Burden of Headache EHF Headache Summer school in Belgrade Rigmor Hoejland Jensen, Professor, Dr.Med.Sci., Danish Headache Center, Department of
Migraine affects about 1 of. Epidemiology of Migraine ...SYMPOSIUM PROCEEDINGS... Based on a presentation by Walter F.
...SYMPOSIUM PROCEEDINGS... Epidemiology of Migraine Based on a presentation by Walter F. Stewart, PhD, MPH Presentation Summary About one of every nine individuals in the United States suffers from migraine.
The global burden of migraine
J Headache Pain (2003) 4:S3 S11 Springer-Verlag 2003 GLOBAL BURDEN Richard B. Lipton Marcelo E. Bigal Ann I. Scher Walter F. Stewart The global burden of migraine R.B. Lipton ( ) M.E. Bigal Department
Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,
Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson
ORIGINAL INVESTIGATION. Burden of Migraine in the United States
Burden of Migraine in the United States Disability and Economic Costs ORIGINAL INVESTIGATION X. Henry Hu, MD, MPH, PhD; Leona E. Markson, ScD; Richard B. Lipton, MD; Walter F. Stewart, PhD, MPH; Marc L.
Prevalence of Migraine Headache in Canada: A Population-Based Survey
International Journal of Epidemiology O International Epidemlologlcal Association 994 Vol. 23, 5 Printed In Great Britain Prevalence of Migraine Headache in Canada: A PopulationBased Survey BERNIE O'BRIEN,*"
Epidemiology and cost of chronic pain
Epidemiology and cost of chronic pain Dr Beverly Collett Consultant in Pain Medicine University Hospitals of Leicester Regional Advisor Treasurer of IASP Epidemiology Chronic pain is defined differently,
Migraine is a very common medical disorder
MENSTRUALLY RELATED MIGRAINE: IMPLICATIONS FOR EMPLOYERS AND MANAGED CARE * Richard B. Lipton, MD ABSTRACT Migraine is a common disorder, affecting approximately 28 million men and women in the United
MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division
MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division The costs of poor mental health Estimates of Direct and Indirect Costs of Mental Illness 1 All
Physiotherapy for tension-type headache: a controlled study
Blackwell Science, LtdOxford, UKCHACephalalgia1468-2982Blackwell Science, 232412936Original ArticlePhysiotherapy for tension-type headachep Torelli et al. Physiotherapy for tension-type headache: a controlled
The impact of headache on quality of life
J Headache Pain (2003) 4:S35 S41 Springer-Verlag 2003 INTANGIBLE COSTING Gisela M. Terwindt Michel D. Ferrari Lenore J. Launer The impact of headache on quality of life G.M. Terwindt ( ) M.D. Ferrari Department
Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache?
J Headache Pain (2004) 5:110 114 DOI 10.1007/s10194-004-0078-5 ORIGINAL Virginie Dousset Virginie Chrysostome Bruno Ruiz S. Irachabal Magalie Lafittau Françoise Radat Bruno Brochet Patrick Henry Does repeated
Underage drinking in Europe
Underage drinking in Europe There are two major studies on underage drinking which are published every 4 years: HBSC (Health Behaviour in School-aged Children) and ESPAD (The European School survey Project
The validity of recognition-based headache diagnoses in adolescents. Data from the Nord-Trøndelag Health Study , Head-HUNT-Youth
Blackwell Science, LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 200323Original Article Recognition-based headache diagnoses in adolescentsj-a Zwart et al. The validity of recognition-based headache
ORIGINAL INVESTIGATION. Headache Evaluation and Treatment by Primary Care Physicians in an Emergency Department in the Era of Triptans
Headache Evaluation and Treatment by Primary Care Physicians in an Emergency Department in the Era of Triptans Morris Maizels, MD ORIGINAL INVESTIGATION Background: Despite advances in treatment, patients
THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures
THE CVD CHALLENGE IN NORTHERN IRELAND Together we can save lives and reduce NHS pressures The challenge of CVD continues today. Around 225,000 people in Northern Ireland live with the burden of cardiovascular
Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe
Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada
Prevalence of Migraine Among School Children (Primary, Preparatory and Secondary) in Assiut City-Egypt
Hamdy El-Tallawy et al. Prevalence of Migraine Among School Children (Primary, Preparatory and Secondary) in Assiut City-Egypt Hamdy N.A. El-Tallawy, Hassan M.M. Farweez, Wafaa M.A. Fargha1y, Nageh F.
MIGRAINE ASSOCIATION OF IRELAND
MIGRAINE ASSOCIATION OF IRELAND HEADACHE IN MEN: THE FACTS This leaflet was composed by Paolo Rossi M.D., Ph.D. of the European Headache Alliance to mark European Migraine Day of Action 2014. Why a leaflet
An Expert System for Headache Diagnosis: The Computerized Headache Assessment Tool (CHAT) Morris Maizels, MD; William J.
Headache 2007 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2007.00918.x Published by Blackwell Publishing Research Submission An Expert System
The health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
Migraine the forgotten epidemic: development of the EHF/WHA Rome Declaration on Migraine
J Headache Pain (2006) DOI 10.1007/s10194-006-0349-4 PUBLIC HEALTH SECTION Hans-Christoph Diener Timothy J. Steiner Stewart J. Tepper Migraine the forgotten epidemic: development of the EHF/WHA Rome Declaration
UK bowel cancer care outcomes: A comparison with Europe
UK bowel cancer care outcomes: A comparison with Europe What is bowel cancer? Bowel cancer, which is also known as colorectal or colon cancer, is a cancer that affects either the colon or the rectum. The
The accident injuries situation
Appendix 2. The accident injuries situation Almost 90 % of injury deaths take place in home and leisure Almost 80 % of accidents leading to injury take place in home and leisure Unintentional injuries
Prof. Dr. Gabor Ternak
Prof. Dr. Gabor Ternak Noninfectious diseases can't be passed from one person to another. Instead, these types of diseases are caused by factors such as the environment, genetics and lifestyle. The term
UNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition
UNDERSTANDING CHRONIC MIGRAINE Learn about diagnosis, management, and treatment options for this headache condition 1 What We re Going to Cover Today The symptoms and phases of migraine Differences between
The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study
J Headache Pain (2010) 11:67 73 DOI 10.1007/s10194-009-0174-7 ORIGINAL The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006 2008 Knut Hagen John-Anker Zwart Anne Hege
The burden and cost of cancer
18 (Supplement 3): iii8 iii22, 2007 doi:10.1093/annonc/mdm097 The burden and cost of cancer summary The incidence of cancer is increasing and the reasons for this are multifactorial. With respect to mortality,
ORIGINAL ARTICLE. Abstract. Introduction
ORIGINAL ARTICLE Prevalence and Characteristics of Headaches in a Socially Active Population Working in the Tokyo Metropolitan Area Surveillance by an Industrial Health Consortium Norihiro Suzuki 1, Yoshiki
PREVALENCE BY HEADACHE TYPE
CLINICAL CLUES AND CLINICAL RULES: PRIMARY VS SECONDARY HEADACHE * Based on a presentation by David W. Dodick, MD ABSTRACT Headache is a common condition, accounting for many specialist office visits annually.
Prevalence of Depression Symptoms in Outpatients with a Complaint of Headache
Prevalence of Depression Symptoms in Outpatients with a Complaint of Headache Robert A. Marlow, MD, MA, Cynthia L. Kegowicz, MD, and Kimberly N. Starkey, BA Purpose: This case-control study was designed
2017 GLOBAL PAIN INDEX (GPI) Better for Everyone
2017 GLOBAL PAIN INDEX (GPI) Better for Everyone Contents: GPI Australia Report 2017 At A Glance Executive Summary Pain Is Everywhere In Australia Pain Makes Us Poorer Professionals Pain Is Isolating We
Economic impact of primary headaches in Turkey: a university hospital based study: part II
J Headache Pain (2006) 7:75 82 DOI 10.1007/s10194-006-0273-7 O R I G I N A L Necdet Karlı Mehmet Zarifo lu Mustafa Ertafl Sabahattin Saip Vesile Öztürk fiebnem Bıçakçı Cavit Boz Deniz Selçuki Atilla O
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
Rheumatoid Arthritis Disease Burden and Access to Treatment
Berlin, April 2012 Rheumatoid Arthritis Disease Burden and Access to Treatment Gisela Kobelt, PhD Visiting Professor, Lund University (Sweden) President, European Health Economics (France) Disclaimers
Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN)
The Costs of Smoking Hana Ross, PhD American Cancer Society and the International Tobacco Evidence Network (ITEN) Why Do We Study the Cost of Smoking? To assess the economic impact of smoking behavior
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
The impact of migraine on work, family, and leisure among young women a multinational study
CURRENT MEDICAL RESEARCH AND OPINION VOL. 20, NO. 10, 2004, 15951604 0300-7995 doi:10.1185/030079904x3357 2004 LIBRAPHARM LIMITED ORIGINAL ARTICLE The impact of migraine on work, family, and leisure among
Single Use of Sumatriptan: A Patient Interview Study
Single Use of Sumatriptan: A Patient Interview Study H. Rahimtoola, PharmD; H. Buurma, PharmD; C.C. Tijssen, PharmD; H.G. Leufkens, PhD; A.C.G. Egberts, PhD Objective. To investigate the possible reasons
Admission criteria to the Danish Brain Cancer Program are moderately associated with magnetic resonance imaging findings
Dan Med J 60/3 March 2013 danish medical JOURNAL 1 Admission criteria to the Danish Brain Cancer Program are moderately associated with magnetic resonance imaging findings Thomas Winther Hill, Mie Kiszka
Classification of headaches
Classification of headaches Jasna Zidverc Trajković Headache center Headache in adults: 1-year prevalence 13.4 Kryst 35.9 Miranda 28.7 Jaillard 87.3 O Brien 63.1 Wiehe 37.3 Lavados 59.7 Schwartz 76.0 Boardman
European Brain Council: Structure and activities. Jes Olesen President European Brain Council (EBC)
European Brain Council: Structure and activities Jes Olesen President European Brain Council (EBC) European Brain Council (EBC) membership EFNS European Federation of Neurological Societies FENS Federation
The Importance of Some Possible Somatic and Environmental Risk Factors for the Development of Migraine
Elmer ress Original Article J Neurol Res. 2015;5(3):193-198 The Importance of Some Possible Somatic and Environmental Risk Factors for the Development of Migraine Han Le a, Peer Tfelt-Hansen a, Axel Skytthe
Treatment of migraine and tension-type headache in Croatia
J Headache Pain (2010) 11:227 234 DOI 10.1007/s10194-010-0200-9 ORIGINAL Treatment of migraine and tension-type headache in Croatia Vlasta Vuković Davor Plavec Arijana Lovrenčić Huzjan Mislav Budišić Vida
Guidelines for the organization of headache education in Europe: the headache school II
J Headache Pain (2010) 11:161 165 DOI 10.1007/s10194-010-0195-2 TUTORIAL Guidelines for the organization of headache education in Europe: the headache school II Rigmor Jensen Dimos D. Mitsikostas Dominique
European Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
Epidemiology of headache in Europe
European Journal of Neurology 2006, 13: 333 345 REVIEW ARTICLE Epidemiology of headache in Europe L. J. Stovner a,b, J.-A. Zwart a,b,c, K. Hagen a,b, G. M. Terwindt d and J. Pascual e a Department of Neuroscience,
The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006261012091213Original ArticleThe prevalence of premonitory symptoms in migrainegg Schoonman et al. The prevalence of premonitory
Palliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact
Sokolovic et al. The Journal of Headache and Pain 2013, 14:29 RESEARCH ARTICLE Open Access Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment,
Public Mental Health. Benedetto Saraceno University Nova of Lisbon University of Geneva Chairman Global Initiative on Psychiatry, The Netherlands
Public Mental Health Benedetto Saraceno University Nova of Lisbon University of Geneva Chairman Global Initiative on Psychiatry, The Netherlands FIVE KEY POINTS IN PMH Mental disorders: high prevalence
Weekly Influenza Surveillance Report. Week 11
Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices
HPV, Cancer and the Vaccination Programme
HPV, Cancer and the Vaccination Programme Dr Brenda Corcoran Consultant in Public Health Medicine HSE National Immunisation Office What is HPV? Human papillomavirus Over 200 types identified Spread by
Cluster headache in women: clinical characteristics and comparison with cluster headache in men
J Neurol Neurosurg Psychiatry 2001;70:613 617 613 Department of Neurology, JeVerson Headache Center, Thomas University Hospital, 111 South 11th Street, Gibbon Building, Suite 8130, Philadelphia, Pennsylvania
Cluster headache and paroxysmal hemicrania: differential diagnosis
Blackwell Science, LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 2004254244248Original ArticleCH and PH: differential diagnosisj Zidverc-Trajkovic et al. Cluster headache and paroxysmal hemicrania:
Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)
Headaches. Mini Medical School. November 10, 2016 A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology) Artist Agnes Cecile Disclosures I have received an honorarium from
European status report on alcohol and health Leadership, awareness and commitment
European status report on alcohol and health 2014 Leadership, awareness and commitment Leadership, awareness and commitment Background Strong leadership from national and local governments is essential
Comparative Analysis of Individuals With and Without Chiropractic Coverage Patient Characteristics, Utilization, and Costs
Comparative Analysis of Individuals With and Without Chiropractic Coverage Patient Characteristics, Utilization, and Costs 1 Archives of Internal Medicine. October 11, 2004;164:1985-1992 Antonio P. Legorreta,
The Burden of Cardiovascular Disease in North Carolina June 2009 Update
The Burden of Cardiovascular Disease in North Carolina June 2009 Update Sara L. Huston, Ph.D. Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section Division of Public Health North Carolina
Comorbidities of Migraine
Comorbidities of Migraine Richard B. Lipton, MD Edwin S Lowe Professor and Vice Chair of Neurology Director, Montefiore Headache Center Albert Einstein College of Medicine Overview What is comorbidity?
Measure Components Numerator Statement
MEASURE #5: OVERUSE OF OPIOID CONTAINING MEDICATIONS FOR PRIMARY HEADACHE DISORDERS Headache For Quality Improvement Only. Not to be used for Public Reporting or Accountability Measure Description Percentage
New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries
New global report highlights silent epidemic of kidney disease and neglect of treatment and prevention in all countries An estimated 1 in 10 people worldwide have chronic kidney disease **Embargo: 18:00H
RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE
RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE Gretchen E. Tietjen, MD University of Toledo Toledo, Ohio Learning objectives At the conclusion of this presentation, participants should be able to: 1. Understand
Overview of European Consumption Databases
FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction
Cluster headache (CH) is a type of primary headache
Real-World Health Plan Claims Analysis of Differences in Healthcare Utilization and Total Cost in Patients Suffering From and Those Without Headache- Related Conditions Michael Polson, MS, PharmD; Todd
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia
(2004) 18, 545 551 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh REVIEW ARTICLE Prevalence, awareness, treatment and control of hypertension in North America,
Lifting The Burden. WHO s Global Campaign to Reduce the Burden of Headache Worldwide. TJ Steiner
Lifting The Burden WHO s Global Campaign to Reduce the Burden of Headache Worldwide TJ Steiner Division of Neuroscience and Mental Health Imperial College London 04/03/09 TJ Steiner 1 The argument (as
A STUDY OF PREVALENCE OF MAJOR DEPRESSIVE DISORDER IN PATIENTS PRIMARILY HAVE HEADACHE AS A SYMPTOM
3 Original article A STUDY OF PREVALENCE OF MAJOR DEPRESSIVE DISORDER IN PATIENTS PRIMARILY HAVE HEADACHE AS A SYMPTOM Dr. Vaishal N. Vora, M.D. (Psychiatry), D.P.M, Consultant Psychiatrist, Chairman,
Overview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
...SELECTED ABSTRACTS...
The following abstracts, from medical journals containing literature on migraine management, were selected for their relevance to this Special Report supplement. Two Sumatriptan Studies Two double-blind
Prevalence and Impact of Migraine and Tension-Type Headache in Korea
ORIGINAL ARTICLE J Clin Neurol 212;8:24-211 Print ISSN 1738-6586 / On-line ISSN 25-513 http://dx.doi.org/1.3988/jcn.212.8.3.24 Open Access Prevalence and Impact of Migraine and Tension-Type Headache in
Inpatient Treatment of Status Migraine With Dihydroergotamine in Children and Adolescents
Headache 2008 the Authors Journal compilation 2008 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2008.01293.x Published by Wiley Periodicals, Inc. Brief Communication Inpatient Treatment
The challenge of obesity in the WHO European Region
Fact sheet EURO/13/05 Copenhagen, Bucharest, 12 September 2005 The challenge of obesity in the WHO European Region Obesity poses one of the greatest public health challenges for the 21st century, with
Measles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
Q1 What age are you?
Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%
NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program
NATIONAL COST OF OBESITY SEMINAR Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program 1 INTRODUCTION According to the Center of Disease Control and Prevention, the American society
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe
Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe 21st Congress of the European Association of Dental Public Health 1 October 2016 Budapest
Table 7.1 Summary information for lung cancer in Ireland,
7 Lung cancer 7.1 Summary Lung cancer is the third most common cancer in Ireland, accounting for 15% of cancers in men and 9% in women, if non-melanoma skin cancer is excluded (table 7.1). Each year, approximately
Controversy One: Headache and Disability. Robert Shapiro, MD, PhD University of Vermont
Controversy One: Headache and Disability Robert Shapiro, MD, PhD University of Vermont Southern Headache Society Orlando, FL, Sept 21, 2013 Disclosures Consulting within the past 12 months: Transcept Pharmaceuticals
ORIGINAL CONTRIBUTION. Efficacy and Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain
ORIGINAL CONTRIBUTION Efficacy and Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain Three Double-blind, Randomized, -Controlled Trials Richard B. Lipton, MD; Walter
Access to treatment and disease burden
Access to treatment and disease burden Robert Flisiak Department of Infectious Diseases and Hepatology Medical University in Białystok, Poland Moulin de Vernègues, 27-29 August 2015 Disclosures Advisor
The Risk of Alcohol in Europe. Bridging the Gap June 2004
The Risk of Alcohol in Europe Bridging the Gap 16-19 June 2004 1. What is the relationship between alcohol and the risk of heart disease? 2. What is the relationship between alcohol and the risk of other
Economic and social impact of migraine
Q J Med 1996; 89:77 84 Economic and social impact of migraine C.E. CLARKE, L. MacMILLAN1, S. SONDHI1 and N.E.J. WELLS1 From the Department of Neurology, Hull Royal Infirmary, Hull, and 1Glaxo Pharmaceuticals
An Epidemiological Study to Assess Migraine Prevalence in a Sample of Italian Population Presenting to Their GPs
Original Paper Eur Neurol 2000;43:102 106 Received: March 5, 1999 Accepted: August 20, 1999 An Epidemiological Study to Assess Migraine Prevalence in a Sample of Italian Population Presenting to Their
State of provision of Hearing Aids in Europe
Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability
European Parkinson s Disease Association
European Parkinson s Disease Association Move for Change Survey Part : Analysis Report Executive Summary... 3 Background... 3 Diagnosis... 3 The Role of Healthcare Professionals... 3 Parkinson s Organisations
Alcohol Under 21 years old. Rory M Doyle, M.Sc Office of the Chief Medical Examiner Washington, DC
Alcohol Under 21 years old Rory M Doyle, M.Sc Office of the Chief Medical Examiner Washington, DC Rory.Doyle@dc.gov EU Drinking Age Limits Country Drinking age Purchase Age Country Drinking Age Purchase
Key Highlights continued
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family
Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.
Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010. WHO/Europe publishes a weekly electronic bulletin on influenza activity in the Region 1 and
Hearing Loss: The Statistics
: The Statistics 2015 Global Statistics It is hard to know precise numbers of how many people experience hearing loss across the EU, Europe, and indeed the world. There are many sources of information
Grown-up congenital heart disease care throughout Europe
Grown-up congenital heart disease care throughout Europe P. Moons, F. Meijboom, H. Baumgartner, P.T. Trindade, E. Huyghe, H. Kaemmerer on behalf of the ESC Working Group on Grown-up Congenital Heart Disease
Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT
Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of twin pairs
J Headache Pain (2006) 7:119 126 DOI 10.1007/s10194-006-0299-x GREPPI-SICUTERI AWARD 2006 Michael Bjørn Russell Jūratė Šaltytė-Benth Niels Levi Are infrequent episodic, frequent episodic and chronic tension-type